MAPT and Alzheimer disease: Knowing that the amyloid plaques and neurofibrillary tangles are pathogenic hallmarks of AD, several biomarkers such as Aβ and total tau detected in cerebrospinal fluid (CSF) are used to detect AD.3 However, the approach for the pathological examinations assessing these biomarkers is invasive.